Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 52: 1763-1770, 2006. First published July 27, 2006; 10.1373/clinchem.2005.063032
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2005.063032v1
52/9/1763    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bronsky, J.
Right arrow Articles by Nevoral, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bronsky, J.
Right arrow Articles by Nevoral, J.
Related Collections
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 2006;52:1763-1770.)
© 2006 American Association for Clinical Chemistry, Inc.


Endocrinology and Metabolism

Adiponectin, Adipocyte Fatty Acid Binding Protein, and Epidermal Fatty Acid Binding Protein: Proteins Newly Identified in Human Breast Milk

Jirí Bronsky1,2,a, Michal Karpísek3, Eva Bronská4, Marta Pechová2, Barbora Jancíková5, Hana Kotolová3, David Stejskal6, Richard Prusa2 and Jirí Nevoral1

1 Pediatric Gastroenterology Unit, Pediatric Clinic, 2nd Medical Faculty, Charles University and University Hospital Motol, Prague, Czech Republic.
2 Department of Clinical Biochemistry and Pathobiochemistry, 2nd Medical Faculty, Charles University and University Hospital Motol, Prague, Czech Republic.
3 Department of Human Pharmacology and Toxicology, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Brno, Czech Republic.
4 National Institute of Public Health and 3rd Medical Faculty, Charles University and University Hospital Bulovka, Prague, Czech Republic.
5 Department of Neonatology, 2nd Medical Faculty, Charles University and University Hospital Motol, Prague, Czech Republic.
6 Department of Laboratory Medicine, Hospital Sternberk, Sternberk, Czech Republic.

aAddress correspondence to this author at: Department of Pediatric Gastroenterology, Pediatric Clinic, 2nd Medical Faculty, Charles University and University Hospital Motol, V Úvalu 84, 150 06, Prague 5, Czech Republic. Fax: 420-22443- 2020; e-mail bronsky{at}email.cz.

Background: Breastfeeding may protect children from developing metabolic syndrome and other diseases later in life. We investigated novel proteins in human breast milk that might play a role in this process.

Methods: We used ELISA to measure adiponectin, adipocyte and epidermal fatty acid binding proteins (AFABP, EFABP), and leptin concentrations in human breast milk obtained from 59 mothers 48 h after initiation of lactation. Using a questionnaire and medical records, we collected information about the mothers and newborns.

Results: Mean (SE) adiponectin concentrations in breast milk were 13.7 (0.8), range 3.9–30.4 µg/L; AFABP concentrations 26.7 (4.4), range 1.2–137.0 µg/L; EFABP concentrations 18.1 (1.4), range 0.8–47.0 µg/L; and leptin concentrations 0.50 (0.05), range 0–1.37 µg/L. We found a significant correlation between AFABP and EFABP concentrations (r = 0.593, P <0.0001). Maternal EFABP concentrations were significantly higher in mothers who delivered boys than in those who delivered girls [21.7 (2.3) vs 15.4 (1.7) µg/L, P = 0.028] and correlated with newborn birth weight (r = 0.266, P = 0.045). Maternal leptin correlated with body weight before pregnancy (r = 0.272, P = 0.043) and at delivery (r = 0.370, P = 0.005), body mass index before pregnancy (r = 0.397, P = 0.003) and at delivery (r = 0.498, P <0.0001), body weight gain during pregnancy (r = 0.267, P = 0.047), and newborn gestational age (r = 0.266, P = 0.048). Leptin was significantly lower in mothers who delivered preterm vs term babies [0.30 (0.09) vs 0.60 (0.05) ug/L, P = 0.026].

Conclusions: Concentrations of adiponectin, AFABP, and EFABP in human breast milk are related to nutritional variables of mothers and newborns and thus may play a role in the protective effects of breastfeeding.




The following articles in journals at HighWire Press have cited this article:


Home page
CMAJHome page
J. G. Ray MD MSc, A. P. Mohllajee MPH, R. M. van Dam PhD, and K. B. Michels ScD PhD
Breast size and risk of type 2 diabetes mellitus
Can. Med. Assoc. J., January 29, 2008; 178(3): 289 - 295.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Association for Clinical Chemistry.